ELEVANCE HEALTH, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
ELEVANCE HEALTH, INC. (ELV) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$593.00 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2020-02-19
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-12-31 was $338.00M.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-09-30 was $84.00M, a 88.45% decline year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-06-30 was $14.00M, a 95.74% decline year-over-year.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-03-31 was -$1.03B.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was -$593.00M, a 586.07% decline from fiscal 2018.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $122.00M, a 86.77% decline from fiscal 2017.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $922.00M, a 406.59% increase from fiscal 2016.
- ELEVANCE HEALTH, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $182.00M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $338.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $422.00M derived: sum of 2 quarters · filed 2020-02-19 | $436.00M derived: sum of 3 quarters · filed 2020-02-19 | -$593.00M 10-K · filed 2020-02-19 | ||||
| 2019-09-30 | $84.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $98.00M derived: sum of 2 quarters · filed 2019-10-23 | -$931.00M 10-Q · filed 2019-10-23 | -$1.56B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2019-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$1.01B 10-Q · filed 2019-07-24 | -$1.65B derived: sum of 3 quarters · filed 2020-02-19 | -$922.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2019-03-31 | -$1.03B 10-Q · filed 2019-04-24 | -$1.66B derived: sum of 2 quarters · filed 2020-02-19 | -$936.00M derived: sum of 3 quarters · filed 2020-02-19 | -$607.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-12-31 | -$634.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $93.00M derived: sum of 2 quarters · filed 2020-02-19 | $422.00M derived: sum of 3 quarters · filed 2020-02-19 | $122.00M 10-K · filed 2020-02-19 | ||||
| 2018-09-30 | $727.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $1.06B derived: sum of 2 quarters · filed 2019-10-23 | $756.00M 10-Q · filed 2019-10-23 | $1.11B derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $329.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $29.00M 10-Q · filed 2019-07-24 | $28.80M 10-Q · filed 2018-07-25 | $388.00M derived: sum of 3 quarters · filed 2020-02-19 | $1.00B derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2018-03-31 | -$300.00M 10-Q · filed 2019-04-24 | -$300.40M 10-Q · filed 2018-04-25 | $59.00M derived: sum of 2 quarters · filed 2020-02-19 | $675.00M derived: sum of 3 quarters · filed 2020-02-19 | $845.80M derived: sum of 4 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $359.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $975.00M derived: sum of 2 quarters · filed 2020-02-19 | $1.15B derived: sum of 3 quarters · filed 2020-02-19 | $922.00M 10-K · filed 2020-02-19 | $921.80M 10-K · filed 2018-02-21 | |||
| 2017-09-30 | $616.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $786.80M derived: sum of 2 quarters · filed 2018-10-31 | $563.00M 10-Q · filed 2018-10-31 | $563.70M 10-Q · filed 2017-10-25 | $658.10M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2017-06-30 | $170.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25 | -$53.00M 10-Q · filed 2018-07-25 | $42.10M derived: sum of 3 quarters · filed 2019-02-20 | -$214.10M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | -$223.80M 10-Q · filed 2018-04-25 | -$128.70M derived: sum of 2 quarters · filed 2019-02-20 | -$384.90M derived: sum of 3 quarters · filed 2019-02-20 | -$108.10M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | $95.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$161.10M derived: sum of 2 quarters · filed 2019-02-20 | $115.70M derived: sum of 3 quarters · filed 2019-02-20 | $182.00M 10-K · filed 2019-02-20 | $116.60M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | -$256.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | $20.60M derived: sum of 2 quarters · filed 2017-10-25 | $86.90M 10-Q · filed 2017-10-25 | $23.30M 10-Q · filed 2016-11-02 | $267.10M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-06-30 | $276.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $343.10M 10-Q · filed 2017-07-26 | $280.00M 10-Q · filed 2016-07-27 | $523.30M derived: sum of 3 quarters · filed 2018-02-21 | -$11.40M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2016-03-31 | $66.30M 10-Q · filed 2017-04-26 | $10.80M 10-Q · filed 2016-04-27 | $246.50M derived: sum of 2 quarters · filed 2018-02-21 | -$288.20M derived: sum of 3 quarters · filed 2018-02-21 | $132.30M derived: sum of 4 quarters · filed 2018-02-21 | |||
| 2015-12-31 | $180.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | -$354.50M derived: sum of 2 quarters · filed 2018-02-21 | $66.00M derived: sum of 3 quarters · filed 2018-02-21 | -$123.40M 10-K · filed 2018-02-21 | -$219.30M 10-K · filed 2016-02-19 | |||
| 2015-09-30 | -$534.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$114.20M derived: sum of 2 quarters · filed 2016-11-02 | -$303.60M 10-Q · filed 2016-11-02 | -$307.50M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $420.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-27 | $231.10M 10-Q · filed 2016-07-27 | $227.20M derived: sum of 3 quarters · filed 2017-02-22 | $3.70M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | -$189.40M 10-Q · filed 2016-04-27 | -$193.30M derived: sum of 2 quarters · filed 2017-02-22 | -$416.80M derived: sum of 3 quarters · filed 2017-02-22 | -$66.50M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$227.40M derived: sum of 2 quarters · filed 2017-02-22 | $122.90M derived: sum of 3 quarters · filed 2017-02-22 | -$14.40M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | -$223.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-28 | $126.80M derived: sum of 2 quarters · filed 2015-10-28 | -$10.50M 10-Q · filed 2015-10-28 | $197.20M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $350.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $213.00M 10-Q · filed 2015-07-29 | $420.70M derived: sum of 3 quarters · filed 2016-02-19 | $580.40M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$137.30M 10-Q · filed 2015-04-29 | $70.40M derived: sum of 2 quarters · filed 2016-02-19 | $230.10M derived: sum of 3 quarters · filed 2016-02-19 | $390.30M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $207.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $367.40M derived: sum of 2 quarters · filed 2016-02-19 | $527.60M derived: sum of 3 quarters · filed 2016-02-19 | $303.60M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $159.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $319.90M derived: sum of 2 quarters · filed 2014-10-29 | $95.90M 10-Q · filed 2014-10-29 | $136.10M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $160.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-30 | -$63.80M 10-Q · filed 2013-07-24 | -$23.60M derived: sum of 3 quarters · filed 2015-02-24 | -$89.90M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$224.00M 10-Q · filed 2014-04-30 | -$183.80M derived: sum of 2 quarters · filed 2015-02-24 | -$250.10M derived: sum of 3 quarters · filed 2015-02-24 | -$242.20M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$26.10M derived: sum of 2 quarters · filed 2015-02-24 | -$18.20M derived: sum of 3 quarters · filed 2015-02-24 | -$406.50M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$66.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$58.40M derived: sum of 2 quarters · filed 2013-10-23 | -$446.70M 10-Q · filed 2013-10-23 | -$243.20M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | $7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-24 | -$380.40M 10-Q · filed 2013-07-24 | -$176.90M derived: sum of 3 quarters · filed 2014-02-20 | -$132.90M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-03-31 | -$388.30M 10-Q · filed 2013-04-24 | -$184.80M derived: sum of 2 quarters · filed 2014-02-20 | -$140.80M derived: sum of 3 quarters · filed 2014-02-20 | -$252.90M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $203.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $247.50M derived: sum of 2 quarters · filed 2014-02-20 | $135.40M derived: sum of 3 quarters · filed 2014-02-20 | -$208.70M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$68.10M derived: sum of 2 quarters · filed 2012-11-07 | -$412.20M 10-Q · filed 2012-11-07 | -$318.00M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-06-30 | -$112.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | -$456.20M 10-Q · filed 2012-07-25 | -$362.00M derived: sum of 3 quarters · filed 2013-02-22 | -$217.60M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2011-03-31 | -$344.10M 10-Q · filed 2012-04-25 | -$249.90M derived: sum of 2 quarters · filed 2013-02-22 | -$105.50M derived: sum of 3 quarters · filed 2013-02-22 | -$113.50M derived: sum of 4 quarters · filed 2013-02-22 | ||||
| 2010-12-31 | $94.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $238.60M derived: sum of 2 quarters · filed 2013-02-22 | $230.60M derived: sum of 3 quarters · filed 2013-02-22 | -$58.20M 10-K · filed 2013-02-22 | ||||
| 2010-09-30 | $144.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26 | $136.40M derived: sum of 2 quarters · filed 2011-10-26 | -$152.40M 10-Q · filed 2011-10-26 | $556.80M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | -$296.80M 10-Q · filed 2011-07-27 | $412.40M derived: sum of 3 quarters · filed 2012-02-22 | $627.70M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | -$288.80M 10-Q · filed 2011-04-27 | $420.40M derived: sum of 2 quarters · filed 2012-02-22 | $635.70M derived: sum of 3 quarters · filed 2012-02-22 | $543.70M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $709.20M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $924.50M derived: sum of 2 quarters · filed 2012-02-22 | $832.50M derived: sum of 3 quarters · filed 2012-02-22 | $952.80M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | $215.30M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $123.30M derived: sum of 2 quarters · filed 2010-11-03 | $243.60M 10-Q · filed 2010-11-03 | $275.00M derived: sum of 4 quarters · filed 2011-02-17 | ||||
| 2009-06-30 | -$92.00M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-03 | $28.30M 10-Q/A · filed 2010-08-03 | $59.70M derived: sum of 3 quarters · filed 2011-02-17 | $118.20M derived: sum of 4 quarters · filed 2011-02-17 | ||||
| 2009-03-31 | $120.30M 10-Q · filed 2010-04-28 | $151.70M derived: sum of 2 quarters · filed 2011-02-17 | $210.20M derived: sum of 3 quarters · filed 2011-02-17 | |||||
| 2008-12-31 | $31.40M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $89.90M derived: sum of 2 quarters · filed 2011-02-17 | -$106.30M 10-K · filed 2011-02-17 | |||||
| 2008-09-30 | $58.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-28 | -$137.70M 10-Q · filed 2009-10-28 | ||||||
| 2008-06-30 | -$196.20M 10-Q · filed 2009-07-29 | |||||||
| 2007-12-31 | -$235.20M 10-K · filed 2010-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |